Alkan; Ozan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Alkan; Ozan.The latest application filed is for "gene editing using a modified closed-ended dna (cedna)".

Company Profile

6.2.12

Alkan; Ozan - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Gene Editing Using A Modified Closed-ended Dna (cedna) App 20220290186 - Kotin; Robert M. ; et al.	2022-09-15
Compositions And Production Of Nicked Closed-ended Dna Vectors App 20220228171 - Alkan; Ozan ; et al.	2022-07-21
Synthetic Production Of Single-stranded Adeno Associated Viral Dna Vectors App 20220220488 - Alkan; Ozan ; et al.	2022-07-14
Closed-ended Dna (cedna) And Use In Methods Of Reducing Gene Or Nucleic Acid Therapy Related Immune Response App 20220119840 - Kerr; Douglas Anthony ; et al.	2022-04-21
Non-viral Dna Vectors And Uses Thereof For Antibody And Fusion Protein Production App 20220042035 - ALKAN; Ozan ; et al.	2022-02-10
Modified Closed-ended Dna (cedna) Comprising Symmetrical Modified Inverted Terminal Repeats App 20210388379 - Kotin; Robert Michael ; et al.	2021-12-16
Inhibiting Ataxia Telangiectasia And Rad3-related Protein (atr) App 20210300905 - DRUMMOND; Daryl C. ; et al.	2021-09-30
Inhibiting ataxia telangiectasia and Rad3-related protein (ATR) Grant 11,028,076 - Drummond , et al. June 8, 2	2021-06-08
Closed-ended Dna Vectors Obtainable From Cell-free Synthesis And Process For Obtaining Cedna Vectors App 20210071197 - Alkan; Ozan ; et al.	2021-03-11
Lipid Nanoparticle Formulations Of Non-viral, Capsid-free Dna Vectors App 20210059953 - Kotin; Robert Michael ; et al.	2021-03-04
Inhibiting Ataxia Telangiectasia And Rad3-related Protein (atr) App 20200399247 - Drummond; Daryl C. ; et al.	2020-12-24
Modified Closed-ended Dna (cedna) App 20200283794 - Kotin; Robert Michael ; et al.	2020-09-10
Inhibiting ataxia telangiectasia and Rad3-related protein (ATR) Grant 10,570,119 - Drummond , et al. Feb	2020-02-25
Inhibiting Ataxia Telangiectasia And Rad3-related Protein (atr) App 20190135789 - Drummond; Daryl C. ; et al.	2019-05-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.